Table 1. Patient profiles.
| Patient Number | Age (years) | Gender | Antiepileptic drugs | Sampled hemisphere | CCEPs | SOZ | Resection area | ILAE seizureoutcome** |
|---|---|---|---|---|---|---|---|---|
| 1 | 11 | F | LEV; OXC | Left | Not performed | Temporal* | Temporal | 1 |
| 2 | 11 | F | LEV; OXC | Right | Performed | Parietal | Parietal | 1 |
| 3 | 11 | F | LEV; OXC | Right | Performed | Frontal | Frontal | 1 |
| 4 | 12 | M | VPA | Left | Performed | Temporal | Temporal | 3 |
| 5 | 13 | F | LEV | Left | Performed | Temporal | Temporal | 1 |
| 6 | 14 | F | LAC; LEV | Right | Not performed | Parietal* | Parietal | 3 |
| 7 | 14 | F | OXC | Left | Not performed | Temporal* | Temporal | 1 |
| 8 | 15 | M | LAC | Right | Not performed | Frontal | Frontal | 1 |
| 9 | 17 | F | LAC; LTG | Left | Performed | Temporal* | Temporal | 1 |
| 10 | 17 | M | LAC; LTG | Right | Not performed | Occipital | Occipital | 1 |
F: Female. M: Male. SOZ: Seizure onset zone. CCEPs: Cortico-cortical evoked potentials. LAC: Lacosamide. LEV: Levetiracetam. LTG: Lamotrigine. OXC: Oxcarbazepine. VPA: Valproate. Five patients failed to undergo the measurement of CCEPs in the present study, due to the insufficient ECoG monitoring period.
*
SOZ was localized at the medial or inferior surface, not visible on the lateral view.
**
Patient 2 underwent focal resection involving the right post-central gyrus and had persistent mild left hemiparesis. None of the other patients developed permanent deficits in motor or speech function.